Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Vodafone Idea shares jump 4%; KM Birla says telco navigated through one of its toughest challenges in history
Vodafone Idea shares climbed after shareholders approved a Rs 4,730 crore investment from the Aditya Birla Group, signalling renewed promoter confidence. With funding support, easing AGR pressure and improved ratings, investor focus now shifts to execution, network expansion and the company’s long-term turnaround prospects.
Markets settle 2% higher: Sensex up 1,700 pts, Nifty above 23,600; five key factors behind broad-based rally - Moneycontrol.com
Markets settle 2% higher: Sensex up 1,700 pts, Nifty above 23,600; five key factors behind broad-based rallyMoneycontrol.com
Why is market rising today? Sensex zooms 1,000 points, Nifty above 23,400. 4 key factors powering the rally
Indian stock markets surged on Friday, with Sensex and Nifty gaining over 1%, driven by optimism surrounding a potential US-Iran peace deal and easing crude oil prices. Hopes of the Strait of Hormuz reopening boosted investor confidence, leading to broad-based gains across sectors and a significant increase in market capitalization.
AB Group reaffirms bet on Voda Idea with ₹4,730 Cr infusion
Vodafone Idea shareholders approved a ₹4,730-crore investment from the Aditya Birla Group via preferential allotment of warrants, increasing AB Group's stake to around 13%. Chairman Kumar Mangalam Birla stated the company's focus now shifts to execution across operations, customer service, and network expansion. This capital infusion will support capital expenditure and loan repayment, reinforcing Vi's financial health.
HFCs emerge stronger after FY26 stress, asset quality recovers sharply; sector better placed for FY27: Report
Housing finance companies have emerged stronger after facing challenges. Asset quality has improved significantly. Loan growth is picking up, and profitability remains resilient. The sector saw a broad-based recovery in the fourth quarter of FY26. This was supported by better collections and healthy disbursement growth. HFCs are now better positioned to handle future challenges.
India's Q4FY26 earnings were red hot. These five charts highlight how they were layered
Corporate India capped off FY26 with its fastest revenue expansion in three years, propelled by a broad-based demand revival. Will this momentum sustain?
IT rout deepens: Nifty IT falls 3%, down 9% in 6 days on risk-off sentiment
Analysts attributed the sustained weakness in the Nifty IT index to broad-based pressure in global technology stocks, cautious sentiment over slower US tech spending, and rising geopolitical tensions
Market Trading Guide: Akums Drugs among 4 stock recommendations for Thursday
Domestic equities ended lower amid global uncertainty and caution ahead of key US inflation data. Despite market weakness, analysts remain bullish on Akums Drugs and Aditya Birla Sun Life AMC after strong technical breakouts, rising volumes and improving momentum indicators.
Tata Consumer crosses Rs 20,000 crore revenue mark in FY26, net profit up 20%
Tata Consumer Products achieved a significant milestone, crossing ₹20,000 crore in revenue for FY26. The company reported a 15% revenue increase and a 20% rise in net profit. Growth was broad-based across India and international markets. Tata Consumer is well-positioned to capitalize on India's consumption growth story. The company noted global economic shifts and trade developments.
Ajanta Pharma promoter sells ₹1,024 crore stake; mutual funds step in as buyers
A promoter entity of Ajanta Pharma has sold a 2.8% stake in the drugmaker for over ₹1,000 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund emerging as the key buyers.
Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MF
A promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya Birla Sun Life Mutual Fund acquiring the stake. The transaction comes amid strong earnings growth, healthy margins and sustained momentum in the company’s pharmaceutical business.
Sensex jumps over 350 points, Nifty above 23,200 as Iran-Israel halt attacks; what lies ahead?
Indian stock markets opened higher, with Sensex and Nifty recovering losses as Iran and Israel agreed to pause attacks, leading to a drop in oil prices. Renewed optimism was broad-based, with mid and small-cap indices outperforming. A US judge's ruling on H-1B fees offered a mild positive for Indian IT stocks.